NCT00079092View on ClinicalTrials.gov

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 1, 2004

Primary Completion Date

March 21, 2006

Study Completion Date

March 21, 2006

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

procarbazine hydrochloride

DRUG

thalidomide

Trial Locations (5)

29303

CCOP - Upstate Carolina, Spartanburg

29615

CCOP - Greenville, Greenville

62526

CCOP - Central Illinois, Decatur

27534-9479

CCOP - Southeast Cancer Control Consortium, Goldsboro

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00079092 - Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma | Biotech Hunter | Biotech Hunter